Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 13,762 | 8,846 | 14,782 | 14,461 | 13,561 |
| TOTAL | $13,762 | $8,846 | $14,782 | $14,461 | $13,561 |
| Non-Current Assets | |||||
| PPE Net | 512,299 | 499,835 | 467,442 | 473,010 | 467,442 |
| Investments And Advances | 31,576 | 3,186 | 2,798 | 2,734 | 2,798 |
| Other Non-Current Assets | 26,322 | 23,697 | 22,591 | 21,368 | 22,591 |
| TOTAL | $570,197 | $526,718 | $492,831 | $497,112 | $492,831 |
| Total Assets | $583,959 | $535,564 | $507,613 | $511,573 | $506,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 39,085 | 24,814 | 82,480 | 76,491 | 82,480 |
| Accounts payable and accrued liabilities | 24,272 | 23,895 | 21,752 | 16,348 | 21,752 |
| Accrued Expenses | 8,735 | 4,971 | 8,629 | 8,188 | 8,629 |
| TOTAL | $78,326 | $66,547 | $128,779 | $120,363 | $128,779 |
| Non-Current Liabilities | |||||
| TOTAL | $68,197 | $66,798 | $65,588 | $65,987 | $65,588 |
| Total Liabilities | $146,523 | $133,345 | $194,367 | $186,350 | $194,367 |
| Shareholders' Equity | |||||
| Common Shares | 41,315 | 132,911 | 109,965 | 140,608 | 27,417 |
| TOTAL | $64,338 | $132,911 | $109,965 | $140,608 | $36,544 |
| Total Liabilities And Equity | $210,861 | $266,256 | $304,332 | $326,958 | $230,911 |